Genetic Biomarkers in Cancer: From Discovery to Clinical Application
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: 10 December 2025 | Viewed by 43
Special Issue Editor
Interests: cancer; tumor biology; biomarkers; cancer therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Genetic biomarkers play a pivotal role in the advancement of precision oncology, enabling early cancer detection, prognosis, and personalized treatment strategies. This review explores the journey of genetic biomarker development, from initial discovery through genomic and transcriptomic profiling to their validation and integration into clinical practice. Key technologies such as next-generation sequencing and bioinformatics tools have accelerated biomarker identification, revealing critical mutations, gene expression patterns, and epigenetic alterations linked to tumorigenesis. Despite significant progress, challenges persist in translating biomarkers from bench to bedside, including issues of reproducibility, cost, and regulatory approval. Notable successes, such as BRCA1/2 in breast cancer and EGFR mutations in non-small-cell lung cancer, highlight the transformative potential of genetic biomarkers in guiding targeted therapies and improving patient outcomes. Continued interdisciplinary collaboration and innovation are essential for expanding the clinical utility of genetic biomarkers across diverse cancer types.
Dr. Evangelos Koustas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- tumor biology
- biomarkers
- cancer therapy
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
